Literature DB >> 7584995

Measurement of glucose in diabetic subjects using noninvasive transdermal extraction.

J A Tamada1, N J Bohannon, R O Potts.   

Abstract

Results from the Diabetes Care and Complications Trial show that tight blood glucose control significantly reduces the long-term complications of diabetes mellitus. In that study, frequent self-testing of glucose and insulin administration resulted in a significant reduction in long-term complications. This protocol, however, also resulted in a threefold increase in the frequency of hypoglycaemic incidents. Currently, self-testing requires a drop of blood for each measurement. The pain and inconvenience of self-testing, along with the fear and danger of hypoglycaemia has led to poor patient acceptance of a tight control regimen, despite the clear long-term advantages. A continuously worn, noninvasive method to periodically measure glucose would provide a convenient and comfortable means of frequent self-testing. A continuously worn device could also alert the user of low glucose levels, thereby reducing the incidence of hypoglycaemia. Guy et al. demonstrated a noninvasive method to transport glucose through the skin using low-level electrical current. To provide a quantitative measurement, the flux of glucose extracted across the skin must correlate with serum glucose in a predictive manner. The results presented here show a quantitative relationship between serum and transdermally extracted glucose in diabetics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584995     DOI: 10.1038/nm1195-1198

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  28 in total

1.  Visualization and analysis of electroosmotic flow in hairless mouse skin.

Authors:  B D Bath; H S White; E R Scott
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring. Interview by Judy Jones.

Authors:  J Pickup; O Rolinski; D Birch
Journal:  BMJ       Date:  1999-11-13

3.  Non-invasive monitoring of gingival crevicular fluid for estimation of blood glucose level.

Authors:  M Yamaguchi; Y Kawabata; S Kambe; K Wårdell; F H Nystrom; K Naitoh; H Yoshida
Journal:  Med Biol Eng Comput       Date:  2004-05       Impact factor: 2.602

4.  Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibration-free glucose monitoring.

Authors:  Anke Sieg; Richard H Guy; M Begoña Delgado-Charro
Journal:  Biophys J       Date:  2004-08-31       Impact factor: 4.033

5.  Conformational stability and domain coupling in D-glucose/D-galactose-binding protein from Escherichia coli.

Authors:  Grzegorz Piszczek; Sabato D'Auria; Maria Staiano; Mosè Rossi; Ann Ginsburg
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

6.  Toward an injectable continuous osmotic glucose sensor.

Authors:  Erik Johannessen; Olga Krushinitskaya; Andrey Sokolov; Häfliger Philipp; Arno Hoogerwerf; Christian Hinderling; Kari Kautio; Jaakko Lenkkeri; Esko Strömmer; Vasily Kondratyev; Tor Inge Tønnessen; Tom Eirik Mollnes; Henrik Jakobsen; Even Zimmer; Bengt Akselsen
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

Review 7.  Current problems and potential techniques in in vivo glucose monitoring.

Authors:  Y Wickramasinghe; Y Yang; S A Spencer
Journal:  J Fluoresc       Date:  2004-09       Impact factor: 2.217

8.  Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances.

Authors:  J Hirvonen; R H Guy
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 9.  Biocompatible materials for continuous glucose monitoring devices.

Authors:  Scott P Nichols; Ahyeon Koh; Wesley L Storm; Jae Ho Shin; Mark H Schoenfisch
Journal:  Chem Rev       Date:  2013-02-07       Impact factor: 60.622

10.  Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling.

Authors:  Benoît Leboulanger; Marc Fathi; Richard H Guy; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.